Authorized Distributor Since 2003 Reports Biocide-Free Clear Choice Products See Increased Q1 Demand as Medical Cannabis Users Face Employment Testing in 38 States Without Workplace Protections
NEW YORK, NY, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This release is for informational purposes only. It does not provide legal, medical, or employment advice. Product legality and permitted uses vary by jurisdiction. Readers should review applicable laws and official product documentation before making any purchase or use decision. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented in this review. All opinions and descriptions are based on publicly available details and are intended to help readers make informed decisions.
Test Negative, an authorized distributor of Clear Choice synthetic urine products since 2003, reports unprecedented research inquiry volume increases as the Q1 2026 employment market navigates ongoing policy tensions between state cannabis legalization frameworks and employer workplace testing programs.
According to Test Negative internal data compiled for January 2, 2026, customer service inquiry volume increased 300% compared to baseline monthly averages, correlating with post-holiday job transition periods and New Year career initiative patterns. The research activity...
Read Full Story:
https://news.google.com/rss/articles/CBMilgJBVV95cUxNLUpxbXZ1MFRNc00yS1FXb1hu...